Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Wunderink

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Critical Care (London, England)|June 10, 2003
The PIRO concept: I is for infectionJean-Louis Vincent, Steven Opal, Antonio Torres, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 18, 2026
Bridging Critically Ill Patients With Cirrhosis to Transplant With Renal Replacement Therapy: A Multicenter Cohort StudyFilipe S Cardoso, Minjee Kim, Beverley Kok, et al.
Critical Care (London, England)|June 10, 2003
The PIRO concept: P is for predispositionDerek C Angus, David Burgner, Richard Wunderink, et al.
Hepatology Communications|January 20, 2023
The impact of multidrug-resistant microorganisms on critically ill patients with cirrhosis in the intensive care unit: a cohort studyMinjee Kim, Filipe S Cardoso, Anna Pawlowski, et al.
American Journal of Respiratory and Critical Care Medicine|September 17, 2005
Preinfection systemic inflammatory markers and risk of hospitalization due to pneumoniaSachin Yende, Elaine I Tuomanen, Richard Wunderink, et al.
Critical Care Medicine|January 23, 2008
A double-blind placebo-controlled study to evaluate the safety and efficacy of L-2-oxothiazolidine-4-carboxylic acid in the treatment of patients with acute respiratory distress syndromePeter E Morris, Peter Papadakos, James A Russell, et al.
Open Forum Infectious Diseases|June 7, 2017
Carbapenem-Resistant <i>Enterobacteriaceae</i> Infections: Results From a Retrospective Series and Implications for the Design of Prospective Clinical TrialsElizabeth L Alexander, Jeffery Loutit, Mario Tumbarello, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2008
Guideline tyranny: a response to the article by Baum and KaltsasLionel Mandell, Richard Wunderink, Antonio Anzueto, et al.
Alimentary Pharmacology & Therapeutics|July 20, 2023
Early serum ammonia variation in critically ill patients with cirrhosis: A multicentre cohort studyFilipe S Cardoso, Minjee Kim, Rui Pereira, et al.
Alimentary Pharmacology & Therapeutics|October 13, 2023
Letter: Exploring the clinical utility of ammonia in critically ill patients with cirrhosis: More to do? Authors' replyFilipe S Cardoso, Minjee Kim, Rui Pereira, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Critical Care (London, England)|June 10, 2003
The PIRO concept: I is for infectionJean-Louis Vincent, Steven Opal, Antonio Torres, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 18, 2026
Bridging Critically Ill Patients With Cirrhosis to Transplant With Renal Replacement Therapy: A Multicenter Cohort StudyFilipe S Cardoso, Minjee Kim, Beverley Kok, et al.
Critical Care (London, England)|June 10, 2003
The PIRO concept: P is for predispositionDerek C Angus, David Burgner, Richard Wunderink, et al.
Hepatology Communications|January 20, 2023
The impact of multidrug-resistant microorganisms on critically ill patients with cirrhosis in the intensive care unit: a cohort studyMinjee Kim, Filipe S Cardoso, Anna Pawlowski, et al.
American Journal of Respiratory and Critical Care Medicine|September 17, 2005
Preinfection systemic inflammatory markers and risk of hospitalization due to pneumoniaSachin Yende, Elaine I Tuomanen, Richard Wunderink, et al.
Critical Care Medicine|January 23, 2008
A double-blind placebo-controlled study to evaluate the safety and efficacy of L-2-oxothiazolidine-4-carboxylic acid in the treatment of patients with acute respiratory distress syndromePeter E Morris, Peter Papadakos, James A Russell, et al.
Open Forum Infectious Diseases|June 7, 2017
Carbapenem-Resistant <i>Enterobacteriaceae</i> Infections: Results From a Retrospective Series and Implications for the Design of Prospective Clinical TrialsElizabeth L Alexander, Jeffery Loutit, Mario Tumbarello, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2008
Guideline tyranny: a response to the article by Baum and KaltsasLionel Mandell, Richard Wunderink, Antonio Anzueto, et al.
Alimentary Pharmacology & Therapeutics|July 20, 2023
Early serum ammonia variation in critically ill patients with cirrhosis: A multicentre cohort studyFilipe S Cardoso, Minjee Kim, Rui Pereira, et al.
Alimentary Pharmacology & Therapeutics|October 13, 2023
Letter: Exploring the clinical utility of ammonia in critically ill patients with cirrhosis: More to do? Authors' replyFilipe S Cardoso, Minjee Kim, Rui Pereira, et al.
Pageof 4